Quick Answer
MAIA Biotechnology, Inc. reported Net Income Loss of -$22.40 million for the year ending 2025.
- MAIA Biotechnology, Inc. showed an increase of +3.7% in Net Income Loss from 2024 to 2025.
- This data is from MAIA Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: -$3.43 million | Q2 2022: -$3.31 million | Q1 2024: -$8.07 million | Q2 2024: -$8.88 million | Q3 2024: -$2.74 million | Q1 2025: -$4.52 million | Q2 2025: -$5.35 million | Q3 2025: -$8.90 million.
- Historical annual values: Fiscal year 2025: -$22.40 million | Fiscal year 2024: -$23.25 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: